市場調査レポート
商品コード
1410776
水頭症シャントの市場規模:セグメント別、シェア、規制、償還、手技、2033年までの予測Hydrocephalus Shunts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
水頭症シャントの市場規模:セグメント別、シェア、規制、償還、手技、2033年までの予測 |
出版日: 2023年12月19日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
脳脊髄液(CSF)シャントシステムによる水頭症の外科的治療は、小児および成人の患者に対して行われる一般的な神経外科手術です。シャントによって、余分な脳脊髄液(CSF)を体の別の部位に排出することができます。
当レポートは、世界の水頭症シャント市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
Hydrocephalus Shunts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Hydrocephalus Shunts market for the year 2020 and beyond. Surgical treatment of hydrocephalus with a Cerebrospinl Fluid (CSF) Shunting system is a common neurosurgery procedure performed on both paediatric and adult patients. Shunts allow excess Cerebrospinal Fluid (CSF) to drain to another area of the body. In this segment, shunt valves and shunt catheters are considered.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Hydrocephalus Shunts and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Medtronic Plc, Integra LifeSciences Holdings Corp, Sophysa SA, Aesculap Inc, Spiegelberg GmbH & Co KG, Natus Medical Inc, Hpbio, G. Surgiwear Ltd and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable